AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 23 June 2008
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Sharma, S.
Right arrow Articles by Qazi, G. N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, S.
Right arrow Articles by Qazi, G. N.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.00045-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Evaluation of Hydroxychavicol for its Antimicrobial, Antioxidant and Anti-inflammatory activity for its Potential Use as Oral Care Agent

Sandeep Sharma, Inshad Ali Khan*, Intzar Ali, Furqan Ali, Manoj Kumar, Ashwani Kumar, Rakesh Kamal Johri, Sheikh Tasduq Abdullah, Sarang Bani, Anjali Pandey, Krishan Avtar Suri, Bishan Datt Gupta, Naresh Kumar Satti, Prabhu Dutt, and Ghulam Nabi Qazi

Biotechnology Division, Pharmacology Division, and Natural Product Chemistry Division, Indian Institute of Integrative Medicine, (CSIR) Canal Road, Jammu, 180001, India

* To whom correspondence should be addressed. Email: iakhan{at}iiim.res.in; inshad@yahoo.com.


   Abstract

Hydroxychavicol isolated from the chloroform extraction of aqueous extract of Piper betle leaves, showed inhibitory activity against oral cavity pathogens. It exhibited inhibitory effect on the entire oral cavity pathogens tested (MICs of 62.5-500 µg/ml) with an MBC, which was two fold greater than the inhibitory concentration. Hydroxychavicol exhibited concentration dependent killing of Streptococcus mutans ATCC 25175 up to 4 x MIC and also prevented the formation of water insoluble glucan. Interestingly hydroxychavicol exhibited an extended PAE of 6 to 7 h and prevented the emergence of mutants of S. mutans ATCC 25175 and Actinomyces viscosus ATCC 15987 at 2X MIC concentration. Furthermore, it also inhibited the S. mutans and A. viscosus generated biofilms and reduced the preformed biofilms by these bacteria. Increased uptake of propidium iodide by hydroxychavicol treated cells of S. mutans and A. viscosus, indicated that hyrdoxychavicol probably works through the disruption of the permeability barrier of microbial membrane structures. Hydroxychavicol also exhibited potent anti-oxidant and anti-inflammatory activities. This was evident from its concentration depended inhibition of lipid peroxidation and significant suppression of TNF-{alpha} expression in human neutrophils Its efficacy against adherent cells of S. mutans in water-insoluble glucan in the presence of sucrose, suggests that the hydroxychavicol would be a useful compound for the development of antibacterial agents against oral pathogens and has great potential for use in mouthwash for preventing and treating oral infections.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.